Advertisement
ASTH vs HCA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and HCA is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 1 FA rating(s) are green whileHCA’s FA Score has 3 green FA rating(s).
- ASTH’s FA Score: 1 green, 4 red.
- HCA’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 5 TA indicator(s) are bullish while HCA’s TA Score has 4 bullish TA indicator(s).
- ASTH’s TA Score: 5 bullish, 4 bearish.
- HCA’s TA Score: 4 bullish, 5 bearish.
Price Growth
ASTH (@Hospital/Nursing Management) experienced а -3.11% price change this week, while HCA (@Hospital/Nursing Management) price change was -0.89% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.21%. For the same industry, the average monthly price growth was -0.38%, and the average quarterly price growth was +6.74%.
Reported Earning Dates
ASTH is expected to report earnings on Feb 19, 2026.
HCA is expected to report earnings on Jan 27, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+0.21% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ASTH | HCA | ASTH / HCA | |
| Capitalization | 1.36B | 109B | 1% |
| EBITDA | 108M | 15B | 1% |
| Gain YTD | 9.311 | 2.669 | 349% |
| P/E Ratio | 142.74 | 18.54 | 770% |
| Revenue | 2.9B | 74.4B | 4% |
| Total Cash | 463M | N/A | - |
| Total Debt | 1.09B | 46.3B | 2% |
ASTH | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 91 | 13 | |
SMR RATING 1..100 | 89 | 43 | |
PRICE GROWTH RATING 1..100 | 45 | 43 | |
P/E GROWTH RATING 1..100 | 2 | 22 | |
SEASONALITY SCORE 1..100 | 46 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (16) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (86) in the null industry. This means that HCA’s stock grew significantly faster than ASTH’s over the last 12 months.
HCA's Profit vs Risk Rating (13) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (91) in the null industry. This means that HCA’s stock grew significantly faster than ASTH’s over the last 12 months.
HCA's SMR Rating (43) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (89) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.
HCA's Price Growth Rating (43) in the Hospital Or Nursing Management industry is in the same range as ASTH (45) in the null industry. This means that HCA’s stock grew similarly to ASTH’s over the last 12 months.
ASTH's P/E Growth Rating (2) in the null industry is in the same range as HCA (22) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to HCA’s over the last 12 months.
| ASTH | HCA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 78% | N/A |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 53% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 68% |
| MACD ODDS (%) | N/A | 2 days ago 66% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 66% |
| Advances ODDS (%) | 3 days ago 78% | 2 days ago 69% |
| Declines ODDS (%) | 15 days ago 75% | 15 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 46% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 53% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EFFE | 23.99 | 0.13 | +0.55% |
| Harbor Osmosis Emerging Markets Resource Efficient ETF | |||
| XONE | 49.56 | N/A | N/A |
| BondBloxx Bloomberg One YrTrgDurUSTrsETF | |||
| AUGZ | 42.94 | N/A | N/A |
| TrueShares Structured Outcome August ETF | |||
| NUSB | 25.25 | N/A | N/A |
| Nuveen Ultra Short Income ETF | |||
| IWO | 343.97 | -0.55 | -0.16% |
| iShares Russell 2000 Growth ETF | |||
ASTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.
| Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
|---|---|---|---|---|
| ASTH | 100% | -7.16% | ||
| ACHC - ASTH | 48% Loosely correlated | -5.14% | ||
| DCGO - ASTH | 40% Loosely correlated | -2.95% | ||
| PNTG - ASTH | 31% Poorly correlated | -0.38% | ||
| UHS - ASTH | 31% Poorly correlated | -2.01% | ||
| HCA - ASTH | 31% Poorly correlated | +1.05% | ||
More | ||||
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.